Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 20/20 | 0.56 |
| ▸ | BRD4 | O60885 | 2/20 | 0.53 |
| ▸ | DDB1 | Q16531 | 4/20 | 0.49 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23413598 | 1.00 | CRBN (0.56) | CRBNBRD4DDB1IKZF3 | |
| SCHEMBL23412691 | 0.83 | CRBN (0.54) | CRBNBRD4DDB1IKZF3 | |
| SCHEMBL23453384 | 0.76 | CRBN (0.61) | CRBNBRD4DDB1IKZF3 | |
| SCHEMBL23413576 | 0.76 | CRBN (0.53) | CRBNBRD4DDB1IKZF3 | |
| SCHEMBL20811955 | 0.75 | CRBN (0.72) | CRBNBRD4DDB1IKZF3 | |
| SCHEMBL23812272 | 0.74 | CRBN (0.68) | CRBNBRD4DDB1IKZF3 | |
| SCHEMBL23799194 | 0.74 | CRBN (0.72) | CRBNBRD4DDB1IKZF3 | |
| SCHEMBL23453743 | 0.73 | CRBN (0.55) | CRBNBRD4DDB1IKZF3 | |
| SCHEMBL20128669 | 0.73 | CRBN (0.71) | CRBNBRD4DDB1IKZF3 | |
| SCHEMBL30918268 | 0.73 | CRBN (0.71) | CRBNBRD4DDB1IKZF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025136129-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET PROTEIN KINASE C | CAPTOR THERAPEUTICS S.A. (PL) | 2025-06-26 | — | — | WO | disclosed |
| EP-4347579-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | Captor Therapeutics S.A. (PL) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022253713-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | CAPTOR THERAPEUTICS S.A. (PL) | 2022-12-08 | — | — | WO | disclosed |